Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
82.8M
-
Number of holders
-
236
-
Total 13F shares, excl. options
-
48.2M
-
Shares change
-
+672K
-
Total reported value, excl. options
-
$590M
-
Value change
-
+$9.04M
-
Put/Call ratio
-
0.8
-
Number of buys
-
100
-
Number of sells
-
-91
-
Price
-
$12.24
Significant Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q3 2022
289 filings reported holding EDIT - Editas Medicine, Inc. - Common Stock as of Q3 2022.
Editas Medicine, Inc. - Common Stock (EDIT) has 236 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.2M shares
of 82.8M outstanding shares and own 58.26% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6.98M shares), VANGUARD GROUP INC (6.73M shares), STATE STREET CORP (6.35M shares), MILLENNIUM MANAGEMENT LLC (1.88M shares), PFM Health Sciences, LP (1.28M shares), GEODE CAPITAL MANAGEMENT, LLC (1.26M shares), JPMORGAN CHASE & CO (1.16M shares), GOLDMAN SACHS GROUP INC (1.12M shares), Capital World Investors (1.1M shares), and TWO SIGMA ADVISERS, LP (1.08M shares).
This table shows the top 236 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.